Oncomedics Overview
- Year Founded
-
2006

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Oncomedics General Information
Description
Provider of biotechnology research services intended to make targeted chemotherapy for each patient in order to increase its effectiveness. The company's services predicts the effect of a molecule on a patient's tumor according to the principle of the antibiogram as well as permit oncologists to personalize the treatment by avoiding drugs that are inactive on the cells and by preferring those with strong anti-cancer activity, enabling clinicians and doctors to receive tested drugs and therapies for the immediate treatment of patients suffering from cancer.
Contact Information
Website
www.oncomedics.comCorporate Office
- ESTER Technopôle
- 1 avenue d'Ester
- 87069 Limoges
- France
Corporate Office
- ESTER Technopôle
- 1 avenue d'Ester
- 87069 Limoges
- France
Oncomedics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | 01-May-2021 | Completed | Generating Revenue | |||
5. Later Stage VC | 15-May-2019 | Completed | Generating Revenue | |||
4. Later Stage VC | 20-Dec-2017 | Completed | Generating Revenue | |||
3. Equity Crowdfunding | 01-Jul-2016 | Completed | Generating Revenue | |||
2. Secondary Transaction - Private | Completed | Startup | ||||
1. Early Stage VC | Completed | Startup |
Oncomedics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary |
Oncomedics Patents
Oncomedics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4381474-A1 | Cell counting method and method for determining the efficacy of a drug candidate | Pending | 04-Aug-2021 | ||
US-20240344011-A1 | Cell counting method and method for determining the efficacy of a drug candidate | Pending | 04-Aug-2021 | ||
EP-4376836-A1 | Compositions and methods for decontaminating and culturing a gastrointestinal tract sample | Pending | 30-Jul-2021 | ||
US-20240368558-A1 | Compositions and methods for decontaminating and culturing a gastrointestinal tract sample | Pending | 30-Jul-2021 | ||
US-20160320316-A1 | Method for determining the cell aggressiveness grade of cancer cells or of cancer stem cells | Inactive | 24-Dec-2013 | G01N22/00 |
Oncomedics Signals
Oncomedics Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AQUITI Gestion | PE/Buyout | Minority | ||
Limousin Business Angels | Angel Group | Minority |
Oncomedics FAQs
-
When was Oncomedics founded?
Oncomedics was founded in 2006.
-
Where is Oncomedics headquartered?
Oncomedics is headquartered in Limoges, France.
-
What is the size of Oncomedics?
Oncomedics has 8 total employees.
-
What industry is Oncomedics in?
Oncomedics’s primary industry is Biotechnology.
-
Is Oncomedics a private or public company?
Oncomedics is a Private company.
-
What is Oncomedics’s current revenue?
The current revenue for Oncomedics is
. -
How much funding has Oncomedics raised over time?
Oncomedics has raised $1.18M.
-
Who are Oncomedics’s investors?
AQUITI Gestion and Limousin Business Angels have invested in Oncomedics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »